Freestone Capital Holdings, LLC Gilead Sciences, Inc. Transaction History

Freestone Capital Holdings, LLC

$2.9 Billion
Q3 2024

A detailed history of Freestone Capital Holdings, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Freestone Capital Holdings, LLC holds 8,994 shares of GILD stock, worth $824,300. This represents 0.03% of its overall portfolio holdings.

Number of Shares

8,994

Previous 9,860 8.78%

Holding current value

$824,300

Previous $676,000 11.39%

% of portfolio

0.03%

Previous 0.02%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $57,666 - $72,735	-866 Reduced 8.78%	8,994 $753,000
Q2 2024 Nov 22, 2024	SELL	$63.15 - $72.88 $45,278 - $52,254	-717 Reduced 6.78%	9,860 $676,000
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $45,278 - $52,254	-717 Reduced 6.78%	9,860 $676,000
Q1 2024 Nov 22, 2024	BUY	$71.58 - $87.29 $113,311 - $138,180	1,583 Added 17.6%	10,577 $774,000
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $31,280 - $38,145	-437 Reduced 3.97%	10,577 $774,000
Q4 2023 Feb 13, 2024	SELL	$73.27 - $83.09 $19,929 - $22,600	-272 Reduced 2.41%	11,014 $892,000
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $371,030 - $404,802	-5,018 Reduced 30.78%	11,286 $845,000
Q2 2023 Aug 09, 2023	SELL	$76.01 - $86.7 $157,112 - $179,208	-2,067 Reduced 11.25%	16,304 $1.26 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $34,248 - $39,019	-443 Reduced 2.35%	18,371 $1.52 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $935,859 - $1.34 Million	-15,017 Reduced 44.39%	18,814 $1.62 Million
Q3 2022 Nov 09, 2022	SELL	$59.54 - $68.01 $865,949 - $989,137	-14,544 Reduced 30.07%	33,831 $2.09 Million
Q2 2022 Aug 09, 2022	SELL	$57.72 - $65.01 $381,990 - $430,236	-6,618 Reduced 12.03%	48,375 $2.99 Million
Q1 2022 May 12, 2022	SELL	$57.92 - $72.58 $55,892 - $70,039	-965 Reduced 1.72%	54,993 $3.27 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $91,480 - $103,832	-1,410 Reduced 2.46%	55,958 $4.06 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $28,023 - $30,234	414 Added 0.73%	57,368 $4.01 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $15,232 - $16,644	-240 Reduced 0.42%	56,954 $3.92 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $139,560 - $159,237	2,326 Added 4.24%	57,194 $3.7 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $543,386 - $619,163	9,592 Added 21.19%	54,868 $3.2 Billion
Q3 2020 Nov 06, 2020	BUY	$62.1 - $78.08 $58,187 - $73,160	937 Added 2.11%	45,276 $2.86 Million
Q2 2020 Aug 04, 2020	SELL	$72.34 - $84.0 $28,357 - $32,928	-392 Reduced 0.88%	44,339 $3.41 Million
Q1 2020 May 12, 2020	SELL	$62.63 - $80.22 $1.19 Million - $1.52 Million	-18,960 Reduced 29.77%	44,731 $3.34 Million
Q4 2019 Feb 04, 2020	SELL	$61.62 - $67.78 $591,367 - $650,484	-9,597 Reduced 13.09%	63,691 $4.14 Million
Q3 2019 Nov 07, 2019	SELL	$62.51 - $69.0 $927,523 - $1.02 Million	-14,838 Reduced 16.84%	73,288 $4.65 Million
Q2 2019 Aug 05, 2019	SELL	$61.87 - $69.38 $9.25 Million - $10.4 Million	-149,581 Reduced 62.93%	88,126 $5.95 Million
Q1 2019 May 08, 2019	BUY	$62.53 - $70.05 $2.45 Million - $2.74 Million	39,185 Added 19.74%	237,707 $15.5 Million
Q4 2018 Feb 12, 2019	SELL	$60.54 - $79.0 $7.47 Million - $9.74 Million	-123,325 Reduced 38.32%	198,522 $12.4 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $443,718 - $491,277	6,225 Added 1.97%	321,847 $24.9 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $316,484 - $369,167	4,878 Added 1.57%	315,622 $22.4 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $1.54 Million - $1.87 Million	21,111 Added 7.29%	310,744 $23.4 Million
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $188,405 - $221,160	2,648 Added 0.92%	289,633 $20.8 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $320,312 - $379,657	4,442 Added 1.57%	286,985 $23.3 Million
Q2 2017 Aug 15, 2017	BUY	N/A	282,543	282,543 $20 Million

Others Institutions Holding GILD

# of Institutions

1,940

Shares Held

989M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $115B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Freestone Capital Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Freestone Capital Holdings, LLC with notifications on news.

Account

Freestone Capital Holdings, LLC Gilead Sciences, Inc. Transaction History